In this quick video, I unpack what physics and information theory can teach us about deal structures in biotech.

Probably, you may not look at a “$3B deal” the same way again.

---

I explain:

• Why the most probable deal isn’t the one you’re hoping for
• What the shape of the deal value curve really tells us
• How this understanding can reframe how you assess risk and opportunity
• Can we design the outcome of deal values?
• If not, what can we do to shift toward the outcomes we want?

---

Thanks for watching! 👋